Abstract:Objective:To study the efficacy of Ziprasidone and Olanzapine in first-visiting patients with acute schizophrenia and the effect on metabolic index.Methods:Eighty inpatients with drug-naive acute schizophrenia were divided into either Olanzapine group(n=44) or Ziprasidone group(n=36) for 4 weeks' treatment.At baseline and the end of observation,The relevant metabolic index level(lipidemia,FBS,insulin,C-peptide,insulin resistence,BMI,waist circumference) were tested respectively,the Positive and Negative Syndrome Scale(PANSS) were evaluated before and after treatment respectively.Results:①After treatment,the scores of PANSS[respectively,(62±16)for total、(13±5)for positive、(16±5)for negative、(28±6)for general psychopathology]in Olanzapine group were significantly lower than baseline level [respectively,(104±14)for total、(25±5)for positive、(24±6)for negative、(44±6)for general psychopathology ](P< 0.01).The scores of PANSS [respectively,(73±21)、(16±5)、(19±8)、(33±10)]after treatment in Ziprasidone group were significantly lower than baseline[respectively,(105±17)、(23±3)、(26±8)、(45±13) ](P< 0.01).The decrease of PANSS total score as well as positive subscale score in Olanzapine group were significantly larger than those in Ziprasidone group(P< 0.01).②After treatment,both weight and BMI in Ziprasidone group increased mildly(P<0.05),however,in Olanzapine group,these metabolic index(including weight,BMI,waist circumference,W/H,insulin,insulin resistence,total cholesterol,triglyceride,LDL,apolipo-protein B100) substantially increased(P<0.01).The rise of weight,waist circumference,W/H,TC,LDL and apolipo-protein B100 in Olanzapine group was far bigger than Ziprasidone group after treatment(P<0.01).Conclusion:Good efficacy was observed among drug-naived acute schizophrenia treated with either Ziprasidone or Olanzapine,similar improvement for negative symptom and general psychopathology were observed among Ziprasidone and Olanzapine group,but Olanzapine showed better efficacy on positive symptom.Comparatively speaking,Ziprasidone has only mild effect on BMI of drug-naived acute schizophrenia and hardly effect on relevant blood glucose and lipidemia.

Comparison of Short-term Metabolic Risk in First-episode Young-adult Schizophrenia Treated with Aripiprazole and Olanzapine

Sex Difference in Effects of Typical and Atypical Antipsychotics on Glucose-Insulin Homeostasis and Lipid Metabolism in First-Episode Schizophrenia.

Study on metabolic risk of first-episode acute schizophrenia patients treated with aripiprazole

Effects of paliperidone extended-release tablets (paliperidoneer) and olanzapine on metabolic profile, weight, insulin resistance and beta-cell function in schizophrenic patients: a randomized 12-week study

A Randomized, 13-Week Study Assessing the Efficacy and Metabolic Effects of Paliperidone Palmitate Injection and Olanzapine in First-Episode Schizophrenia Patients

The comparison of the efficacy of Ziprasidone and Olanzapine in first-visiting patients with acute schizophrenia and the effect on metabolic index

Comparison of metabolic effects of ziprasidone versus olanzapine treatment in patients with first-episode schizophrenia

A randomized, 12-week study of the effects of extended-release paliperidone (paliperidone ER) and olanzapine on metabolic profile, weight, insulin resistance, and β-cell function in schizophrenic patients

Paliperidone Extended Release Versus Olanzapine in Treatment-Resistant Schizophrenia A Randomized, Double-Blind, Multicenter Study

[Effects of Ziprasidone and Olanzapine on Glucose and Lipid Metabolism in First-Episode Schizophrenia].

The Comparison of Glycometabolism Parameters and Lipid Profiles Between Drug-Naïve, First-Episode Schizophrenia Patients and Healthy Controls

Evaluation of Clinical Correlation between Insulin Resistance and Antipsychotic Drug Therapy in Patients with Schizophrenia

Efficacy and safety of ziprasidone versus Olanzapine in first-episode schizophrenia:a 6-week,multicenter,randomized,flexible-dose study

Weight Changes Following Treatment with Aripiprazole, Risperidone and Olanzapine: A 12-Month Study of First-episode Schizophrenia Patients in China

Influence of Atypical Antipsychotics on the Glucose and Lipid Metabolism of Female First-Episode Schizophrenia

The metabolic effects of antipsychotics in the early stage of treatment in first-episode patients with schizophrenia: A real-world study in a naturalistic setting

Effect of Aripiprazole and Olanzapine on blood glucose and lipids of patients with schizophrenia：meta-analysis

Metabolic Effects Of 7 Antipsychotics On Patients With Schizophrenia: A Short-Term, Randomized, Open-Label, Multicenter, Pharmacologic Trial

Double-blind,double-dummy and randomized controlled study of aripiprazole in the treatment of acute schizophrenia

The effects of risperidone and olanzapine on the glucose metabolism and lipid metabolism in elderly patients with schizophrenia

An Open-Label Randomised Comparison of Aripiprazole, Olanzapine and Risperidone for the Acute Treatment of First-Episode Schizophrenia: Eight-week Outcomes.